Table 3 Univariate and multivariate analyses for overall survival in women with ovarian non-serous carcinoma
OSa | Eventsb | Univariate | Multivariate | |||
|---|---|---|---|---|---|---|
p | HR | CI 95% | p | |||
Age, y | ||||||
≤53 | 61.5% | 29/87 (33.3%) | 0.004 | |||
> 53 | 40.9% | 51/92 (55.4%) | ||||
Menopausal Status | ||||||
Premenopausal | 66.4% | 21/70 (30%) | 0.001 | |||
Postmenopausal | 40.8% | 59/109 (54.1%) | ||||
Histologic type | ||||||
Clear | 40.4% | 26/48 (54.1%) | 0.335 | |||
Müsinöz | 55.8% | 23/47 (48.9%) | ||||
Endometrioid | 51.7% | 21/52 (40.4%) | ||||
Mixt | 59.9% | 10/32 (31.2%) | ||||
Route of Spread | ||||||
Intraperitoneal | 54% | 31/72 (43%) | 0.011 | |||
Retroperitoneal | 74.4% | 10/35 (28.6%) | ||||
Intra+Retroperitoneal | 36% | 39/72 (54.1%) | ||||
Peritoneal cytology | ||||||
Positive | 50.5% | 51/118 (43.2%) | 0.987 | |||
Negative | 51.1% | 29/61 (47.5%) | ||||
Bilateralty | ||||||
Unilateral | 59.7% | 40/97 (41.2%) | 0.293 | |||
Bilateral | 40.2% | 40/82 (48.7%) | ||||
Tumor size(cm) | ||||||
< 10 | 47.7% | 38/78 (48.7%) | 0.169 | |||
≥ 10 | 53.5% | 42/101 (41.6%) | ||||
CA-125(IU/ml) | ||||||
< 250 | 56.2% | 39/88 (44.3%) | 0.690 | |||
≥ 250 | 44.5% | 39/84 (46.4%) | ||||
Ascites | ||||||
Yes | 45.4% | 50/100 (50%) | 0.150 | |||
No | 58.1% | 30/79 (37.9%) | ||||
LN involvement | ||||||
Yes | 49% | 49/107 (45.8%) | 0.955 | |||
No | 54% | 31/72 (43%) | ||||
Omental involvement | ||||||
Yes | 38.9% | 57/106 (53.7%) | 0.001 | |||
No | 66.8% | 22/71 (30.9%) | ||||
Grade | ||||||
G1-2 | 69% | 19/69 (27.5%) | 0.003 | 1.9 | 1.071-3.421 | 0.028 |
G3 | 42% | 35/67 (52.2%) | ||||
CRS | ||||||
Maximal | 94.5% | 4/51 (7.8%) | < 0.001 | 5.5 | 1.968-15.625 | 0.001 |
Optimal | 36.2% | 76/128 (59.3%) | ||||